Feb 08 2024 22 mins
In this episode, Nina Bhardwaj, MD, PhD, a PICI Network Investigator and the Director of Immunotherapy at the Icahn School of Medicine at Mount Sinai, sits down with PICI Chief Scientific Officer John Connolly, PhD, for an in-depth conversation about her journey from rheumatology to cancer immunology.
Listen to Dr. Bhardwaj, who also holds the position of Ward-Coleman Chair in Cancer Research at the Icahn School of Medicine at Mount Sinai, discuss her groundbreaking research in modulating the immune system, the evolution of treatment methods, personalized vaccines using tumor-encoded mutant antigens and the role of mentorship in conquering cancer.
Get ready to go from bench to fireside with Dr. Bhardwaj.
++
From Bench to Fireside™ is a new podcast from the Parker Institute for Cancer Immunotherapy (PICI) that takes you from behind the lab bench to the frontiers of cancer research. Each episode features an interview with members of the PICI Network, pioneers in cancer immunotherapy and leaders at world-renowned cancer research institutions. Throughout the conversations, these experts weigh in on the potential of the human immune system to target and eradicate cancer cells, from the latest breakthroughs in immuno-oncology to their impact on patients. Along the way, they unpack the hurdles encountered and the opportunities that lie ahead.
Tune in to hear from scientific leaders who stand at the forefront of developing breakthrough immune therapies with the goal of turning all cancers into curable diseases. From Bench to Fireside™ is produced by the Parker Institute for Cancer Immunotherapy. Follow PICI on LinkedIn, X @parkerici or visit www.parkerici.org.